Derek Archila
Stock Analyst at Wells Fargo
Total Price Targets
32
Stocks Covered
18
Sectors
Healthcare
Most Recent
Jan 29, 2026
Notable Calls (Last 12 Months)
Most Bullish
Stocks Covered by Derek Archila
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| NRIX | Nurix Therapeutics, Inc. | $29.00 | $16.83 | +72.3% | 3 | Jan 29, 2026 |
| SLNO | Soleno Therapeutics, Inc. | $114.00 | $52.86 | +115.7% | 2 | Jan 20, 2026 |
| RYTM | Rhythm Pharmaceuticals, Inc. | $145.00 | $82.41 | +75.9% | 1 | Jan 20, 2026 |
| ALMS | Alumis Inc. Common Stock | $39.00 | $25.27 | +54.3% | 1 | Jan 6, 2026 |
| KYMR | Kymera Therapeutics, Inc. | $116.00 | $81.54 | +42.3% | 2 | Dec 9, 2025 |
| INCY | Incyte Corporation | $116.00 | $96.41 | +20.3% | 2 | Dec 8, 2025 |
| SEPN | Septerna, Inc. | $28.00 | $23.71 | +18.1% | 3 | Nov 14, 2025 |
| EXEL | Exelixis, Inc. | $30.00 | $43.81 | -31.5% | 1 | Oct 21, 2025 |
| CCCC | C4 Therapeutics, Inc. | $10.00 | $2.90 | +244.2% | 2 | Sep 23, 2025 |
| ATYR | aTyr Pharma, Inc. | $1.00 | $0.83 | +20.3% | 1 | Sep 15, 2025 |
| ARVN | Arvinas, Inc. | $26.00 | $10.55 | +146.4% | 3 | Mar 12, 2025 |
| ZYME | Zymeworks Inc. | $12.00 | $26.93 | -55.4% | 1 | Nov 1, 2024 |
| CLDX | Celldex Therapeutics, Inc. | $44.00 | $32.29 | +36.3% | 2 | Sep 25, 2024 |
| ANNX | Annexon, Inc. | $14.00 | $5.80 | +141.4% | 3 | Jun 5, 2024 |
| APLS | Apellis Pharmaceuticals, Inc. | $48.00 | $40.95 | +17.2% | 2 | May 23, 2024 |
| CGC | Canopy Growth Corporation | $8.00 | $1.13 | +608.0% | 1 | Dec 6, 2021 |
| MDGL | Madrigal Pharmaceuticals, Inc. | $130.00 | $516.66 | -74.8% | 1 | May 6, 2021 |
| ESPR | Esperion Therapeutics, Inc. | $20.00 | $3.12 | +541.2% | 1 | May 4, 2021 |
Recent Activity
- Jan 29, 2026— Set$29.00price target onNRIX(Nurix Therapeutics, Inc.)
- Jan 20, 2026— Set$145.00price target onRYTM(Rhythm Pharmaceuticals, Inc.)
- Jan 20, 2026— Set$114.00price target onSLNO(Soleno Therapeutics, Inc.)
- Jan 6, 2026— Set$39.00price target onALMS(Alumis Inc. Common Stock)
- Dec 9, 2025— Set$116.00price target onKYMR(Kymera Therapeutics, Inc.)
- Dec 8, 2025— Set$116.00price target onINCY(Incyte Corporation)
- Nov 14, 2025— Set$28.00price target onSEPN(Septerna, Inc.)
- Nov 5, 2025— Set$106.00price target onSLNO(Soleno Therapeutics, Inc.)
- Oct 29, 2025— Set$97.00price target onINCY(Incyte Corporation)
- Oct 21, 2025— Set$30.00price target onEXEL(Exelixis, Inc.)
- Sep 23, 2025— Set$10.00price target onCCCC(C4 Therapeutics, Inc.)
- Sep 15, 2025— Set$1.00price target onATYR(aTyr Pharma, Inc.)
- May 16, 2025— Set$18.00price target onSEPN(Septerna, Inc.)
- Mar 12, 2025— Set$26.00price target onARVN(Arvinas, Inc.)
- Feb 18, 2025— Set$14.00price target onSEPN(Septerna, Inc.)
- Dec 19, 2024— Set$12.00price target onCCCC(C4 Therapeutics, Inc.)
- Dec 2, 2024— Set$57.00price target onKYMR(Kymera Therapeutics, Inc.)
- Nov 1, 2024— Set$12.00price target onZYME(Zymeworks Inc.)
- Oct 15, 2024— Set$32.00price target onNRIX(Nurix Therapeutics, Inc.)
- Sep 25, 2024— Set$44.00price target onCLDX(Celldex Therapeutics, Inc.)
Frequently Asked Questions
Who is Derek Archila?
Derek Archila is a stock analyst at Wells Fargo covering 18 stocks primarily in Healthcare. They have issued 32 price targets since May 4, 2021.
What stocks does Derek Archila cover?
Derek Archila currently covers 18 stocks, including NRIX, SEPN, ARVN, ANNX, SLNO.
What is Derek Archila's latest price target?
Derek Archila's most recent price target was $29.00 on NRIX (Nurix Therapeutics, Inc.), set on Jan 29, 2026.
What is Derek Archila's highest price target?
Derek Archila's highest issued price target is $145.00 on RYTM, set on Jan 20, 2026.
More Analysts at Wells Fargo
Coverage based on publicly published price targets. Not investment advice.